Dragani A et al. |
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. |
2010 |
Blood |
pmid:19887674
|
Carroll RC et al. |
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. |
2010 |
Thromb. Res. |
pmid:19962724
|
Alusik S et al. |
The inhibitory effect of statins on urinary 11-dehydrothromboxane levels. |
2010 |
Int Angiol |
pmid:20502413
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Montine TJ et al. |
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. |
2010 |
PLoS ONE |
pmid:20174466
|
Zisman E et al. |
Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. |
2010 |
Eur J Anaesthesiol |
pmid:20035230
|
Boizel R et al. |
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes. |
2010 |
Diabetologia |
pmid:20535444
|
Cavalca V et al. |
Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry. |
2010 |
Anal. Biochem. |
pmid:19825360
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Yassine HN et al. |
Clinical determinants of aspirin resistance in diabetes. |
2010 |
Diabetes Res. Clin. Pract. |
pmid:20719400
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Fukushima H et al. |
Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. |
2010 |
Am. J. Med. Genet. A |
pmid:20583254
|
Ferrante E et al. |
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. |
2010 |
Free Radic. Biol. Med. |
pmid:20541603
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Santilli F et al. |
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. |
2010 |
J. Thromb. Haemost. |
pmid:20088941
|
Addad F et al. |
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. |
2010 |
J. Thromb. Thrombolysis |
pmid:19381450
|
Thomson VS et al. |
Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events. |
2009 Oct-Dec |
J Postgrad Med |
pmid:20083870
|
Dietrich-Muszalska A and Olas B |
Isoprostenes as indicators of oxidative stress in schizophrenia. |
2009 |
World J. Biol. Psychiatry |
pmid:19673085
|
Lowe FJ et al. |
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. |
2009 |
Clin. Chem. Lab. Med. |
pmid:19676143
|
Stanke-Labesque F et al. |
Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. |
2009 |
J. Allergy Clin. Immunol. |
pmid:19596146
|
Calapai G et al. |
Cardiovascular biomarkers in groups of established smokers after a decade of smoking. |
2009 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19175368
|
Guagnano MT et al. |
Determinants of platelet activation in hypertensives with microalbuminuria. |
2009 |
Free Radic. Biol. Med. |
pmid:19280705
|
Shen H et al. |
Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). |
2009 |
Am. J. Cardiol. |
pmid:19660620
|
Lauring B et al. |
Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects. |
2009 |
J Clin Pharmacol |
pmid:19833861
|
Cattaneo M |
Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". |
2009 |
Circulation |
pmid:19546394
|
Blais N et al. |
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). |
2009 |
Thromb. Haemost. |
pmid:19652893
|
Heistein LC et al. |
Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms. |
2008 |
Pediatr Cardiol |
pmid:17896127
|
Lee CR et al. |
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. |
2008 |
Clin. Pharmacol. Ther. |
pmid:17495879
|
Patrignani P et al. |
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study. |
2008 |
Pharmacogenet. Genomics |
pmid:18551041
|
Helgason CM et al. |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. |
2008 |
Cerebrovasc. Dis. |
pmid:18349532
|
Geske FJ et al. |
AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect. |
2008 |
Mol Diagn Ther |
pmid:18288882
|
Signore C et al. |
Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day. |
2008 |
Alcohol. Clin. Exp. Res. |
pmid:18715278
|
Roethig HJ et al. |
A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. |
2008 |
J Clin Pharmacol |
pmid:18319361
|
Karon BS et al. |
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. |
2008 |
Clin. Chem. |
pmid:18420732
|
Bruce EC et al. |
Platelet thromboxane A2 secretion in patients with major depression responsive to electroconvulsive therapy. |
2008 |
Psychosom Med |
pmid:18378867
|
Eikelboom JW et al. |
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. |
2008 |
Circulation |
pmid:18838564
|
Ciabattoni G et al. |
Determinants of platelet activation in Alzheimer's disease. |
2007 |
Neurobiol. Aging |
pmid:16442186
|
Chakroun T et al. |
Screening for aspirin resistance in stable coronary artery patients by three different tests. |
2007 |
Thromb. Res. |
pmid:17553552
|
Maree AO and Fitzgerald DJ |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. |
2007 |
Circulation |
pmid:17452618
|
Schwartz JI et al. |
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. |
2007 |
J Clin Pharmacol |
pmid:17925592
|
Baltzer WI et al. |
Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. |
2006 |
Am. J. Vet. Res. |
pmid:16426215
|
Faraday N et al. |
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. |
2006 |
Am. J. Cardiol. |
pmid:16950183
|
Renda G et al. |
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. |
2006 |
Clin. Pharmacol. Ther. |
pmid:16952493
|
Markuszewski L et al. |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16635110
|
Laleman W et al. |
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. |
2006 |
Eur. J. Clin. Invest. |
pmid:16620286
|
Ohmori T et al. |
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. |
2006 |
J. Thromb. Haemost. |
pmid:16706971
|
Santilli F et al. |
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. |
2006 |
J. Am. Coll. Cardiol. |
pmid:16412866
|
Davì G et al. |
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15472127
|
Kataoka M et al. |
A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. |
2005 |
Am. J. Respir. Crit. Care Med. |
pmid:16192456
|
Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|